Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02122900 · ClinicalTrials.gov registry record
Prospective Balloon Aortic Valvuloplasty
A clinical trial, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 100
- Enrollment target
NCT02122900: Completed study, sponsored by Baylor Research Institute.
NCT02122900 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02122900 has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the reasons for balloon aortic valvuloplasty (BAV) in the current clinical setting and to determine the outcomes of BAV in patients with aortic stenosis. The ultimate aim is to establish the safety, effectiveness, and appropriate role of BAV therapy as definitive therapy (palliation) or as a "bridge" to surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR).
Primary Outcome
This is an observational study intended to collect re-world safety outcomes of BAV and delineate if patients that undergo this procedure to improve their clinical status actually improve to a point that they qualify for a definitive treatment for their aortic stenosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-12 |
What the finished NCT02122900 record still lists
NCT02122900 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02122900 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02122900 about?
NCT02122900 is a clinical study titled "Prospective Balloon Aortic Valvuloplasty". The primary objective of this study is to determine the reasons for balloon aortic valvuloplasty (BAV) in the current clinical setting and to determine the outcomes of BAV in patients with aortic stenosis. The ultimate aim is to establish the safety, effectiveness, and appropriate role of BAV therap...
What is the current status of trial NCT02122900?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-06. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT02122900?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia